PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
October 11, 2025Journal of Molecular BiologyOpen Access

Rising Stars: Molecular Mechanisms and Chemical Interventions of α-Synuclein Amyloid Aggregation in Parkinson’s Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SZShengnan ZhangKLKaien LiuDLDan Li

Discussion

Loading...

Member takes

Overview

Research demonstrates chemical interventions targeting α-synuclein aggregation in Parkinson's disease, suggesting new therapeutic strategies.

Key Points

  • Targeting the C-terminal region of α-synuclein reduces toxicity in cellular models, providing a potential treatment avenue.
  • Atomic-resolution structures of α-synuclein fibrils revealed polymorphs linked to differing disease phenotypes, which impacts progression.
  • Studies utilizing biochemical and cellular analyses highlighted important receptor interactions contributing to inflammation in Parkinson's disease.
  • These findings pave the way for precision diagnostics and targeted interventions in neurodegenerative disorders related to α-synuclein.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68ea72339f1bd4df558ceda4https://doi.org/10.1016/j.jmb.2025.169475
View Full Paper
Ask AI
Bookmark
Share